Biosimilars Market in the United States: Analysis, Trends, Growth, and Market Share
The U.S. biosimilars market is projected to surpass USD 375.5 billion by 2033, with a robust compound annual growth rate (CAGR) of 39.45% from 2023 to 2033. Key factors fueling this market expansion include the rising incidence of cancer, an aging population, and a supportive regulatory environment. Biosimilars, which are biologic medical products that closely resemble already approved biological medicines, are at the forefront of this growth.